Clinical Trial Update: Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports adding venetoclax to fludarabine and busulfan conditioning before transplant and to maintenance therapy for AML, MDS, CMML, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Myeloproliferative Neoplasm Unclassifiable
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• Venclexta (venetoclax)

Snippet

Sponsor: Jacqueline Garcia, MD | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 1 | Status: ACTIVE_NOT_RECRUITING